<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7413836\results\search\testTrace\results.xml">
  <result pre="being conducted to test possible therapies. To assist this, virtual" exact="screening" post="via molecular docking was performed on several FDA-approved drugs,"/>
  <result pre="drugs and the top ten hits, previously used in the" exact="treatment" post="of malarial, fungal/bacterial and Ebola infections and FDA-approved/fast-tracked for"/>
  <result pre="al. 2004; Lengauer and Rarey 1996). In this study, virtual" exact="screening" post="of several FDA-approved/fast-tracked drugs was performed against the SARS-CoV-2"/>
  <result pre="by Chimerix Inc. of Durham, North Carolina, USA, for the" exact="treatment" post="of double-stranded DNA (dsDNA) viruses (Lanier et al. 2010)."/>
  <result pre="vitroÂ tests have also shown the drug potential for the" exact="treatment" post="ofÂ Ebola virus disease, despite that Ebola is an"/>
  <result pre="issue an Emergency Use Authorization to be tested as a" exact="treatment" post="for COVID-19, ranked at the fourth position in this"/>
  <result pre="to screen for potential anti-SARS-CoV-2 therapeutic agents. After a virtual" exact="screening" post="against SARS-CoV-2 protease and ACE2 receptor, a set of"/>
  <result pre="safety profile of brincidofovir: a favorable benefitâ€&quot;risk proposition in the" exact="treatment" post="of smallpoxAntivir Res201714326927710.1016/j.antiviral.2017.01.00928093339 Control CfD, Prevention (2014) Vaccine testing"/>
  <result pre="the treatment of smallpoxAntivir Res201714326927710.1016/j.antiviral.2017.01.00928093339 Control CfD, Prevention (2014) Vaccine" exact="testing" post="and the approval process. Webpage. Updated: May DunningJet al.Experimental"/>
  <result pre="testing and the approval process. Webpage. Updated: May DunningJet al.Experimental" exact="treatment" post="of Ebola virus disease with brincidofovirPLOS ONE201611e016219910.1371/journal.pone.016219927611077 FlorescuDFKeckMADevelopment of"/>
  <result pre="disease with brincidofovirPLOS ONE201611e016219910.1371/journal.pone.016219927611077 FlorescuDFKeckMADevelopment of CMX001 (Brincidofovir) for the" exact="treatment" post="of serious diseases or conditions caused by dsDNA virusesExpert"/>
  <result pre="global approvalDrugs2018781517152310.1007/s40265-018-0979-230229442 GaoJTianZYangXBreakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBioSci Trends202014727310.5582/bst.2020.0104732074550 GSK"/>
  <result pre="Int J Pharm Res. 10.31838/ijpr/2020.12.03.070 KitchenDBDecornezHFurrJRBajorathJDocking and scoring in virtual" exact="screening" post="for drug discovery: methods and applicationsNat Rev Drug Discov2004393594910.1038/nrd154915520816"/>
  <result pre="applicationsNat Rev Drug Discov2004393594910.1038/nrd154915520816 LanierRet al.Development of CMX001 for the" exact="treatment" post="of poxvirus infectionsViruses201022740276210.3390/v212274021499452 LengauerTRareyMComputational methods for biomolecular dockingCurr Opin"/>
 </snippets>
</snippetsTree>
